Statement on the Safeguard American Voter Eligibility (SAVE) Act
On March 17, 2026, the U.S. Senate began discussions on the Safeguard American Voter Eligibility (SAVE) Act, which aims to address allegations of widespread voter fraud and election integrity by introducing more stringent requirements for personal identification and proof of citizenship. However, this may impose additional barriers by shifting the burden of proving eligibility to the individual voter, potentially reducing civic participation.
What changes are proposed?
The SAVE Act requires:
- Proof of U.S. citizenship using a birth certificate, passport, or naturalization certificate for voter registration
- A government-issued photo identification for requesting and submitting mail-in ballots
- States to verify voter eligibility through federal databases in coordination with the Department of Homeland Security
How could this affect you?
- Roughly half of U.S. citizens do not have a passport, meaning they may need to rely on a birth certificate for voter registration
- REAL IDs in many states do not indicate citizenship, making them insufficient for verification without additional proof of citizenship
- About 80% of women in heterosexual marriages take their partner’s last name, complicating their ability to register without proof of legal name change
- Stricter registration requirements could reduce the accessibility of voter registration through online and in-person voter registration drives
- Potential changes in status (e.g., name changes, naturalization, moving to other states) could lead to ballots being flagged during federal verification, and in some cases, not counted
- The financial burden to acquire the documents necessary to register to vote may create barriers for those facing financial strain
- To vote by mail, voters may need to send a copy of their ID to request a ballot, and another copy when they submit their ballot
Why does this matter?
National APAMSA strongly condemns this bill due to its potential to create barriers to civic participation and equitable access to voting. These changes may disproportionately impact communities with limited access to documentation, including naturalized citizens and historically marginalized populations. In alignment with our policy compendium and as mentioned in previous statements, National APAMSA recognizes that access to voting is a critical social determinant of health, with direct implications for both individual and community well-being.
What can you do?
We urge you to contact your local senator to express your opposition to the SAVE Act. Resources such as 5 Calls and When We All Vote can help you find and reach your elected officials.
For questions regarding this statement, please contact the Rapid Response Director, Pehr Williamson at rapidresponse@apamsa.org
April 2026: Bootcamp Series
April 2026: Bootcamp Series
Each bootcamp is a two-hour workshop led by residents and early-career attendings offering high-yield information to help with preparations for sub-internships and intern year. Many high-yield topics are also relevant to third-year medical students preparing for clerkships, making our Bootcamp Series valuable for a broad range of learners across the country (and even internationally).
April 4th, 2026

Kevin Hon, DO
Assistant Program Director
St. Barnabas Health

Rahul Kathard, MD
PGY-3
Temple University

Rodan Mecano, DO
PGY-3
William Beaumont University Hospital

Nguyen Lu, MD
Chief Resident
Boston Medical Center

Monette Veral, MD
Attending
UCLA

Katrina Alcantara, MD
PGY-1
UCI

Estelle Green, MD
PGY-2
Boston Children's Hospital

Jennifer Lin, MD
PGY-3
Weill Cornell Medicine

Joyce Lee, MD
PGY-2
UCLA

Athena Dong, MD
PGY-2
USC

Allison Zhong, MD
PGY-4
Mass General Brigham
April 9th, 2026

Christopher Wan, MD
PGY-1
Mount Sinai/ Morningside West

Poojajeet Khaira, MD
PGY-4
Case Western Reserve University-MetroHealth

Mary Shen, MD
PGY-4
Brigham and Women's Hospital, Harvard Medical School
April 11th, 2026

Nance Yuan, MD
Plastic Surgery
Attending
Private Practice

Arlene Zhou, DO
General Surgery
PGY-5
HUMC

Victoria Cegielski, MD
Ophthalmology
PGY-2
OHSU Casey Eye Institute

Frank Qian, MD, MPH
Cardiovascular Medicine Fellow
Boston Medical Center

Yoojin Kim, MD
Cardiovascular Disease Fellow
Duke University

Tej Ganti, MD
Attending
Indiana Regional Medical Center

Connie Lu, MD
Complex Planning Fellow
UIC

Cecilia Gambala, MD
MFM Attending
Tulane
April 12th, 2026

Jennifer Huang, MD, MEd
Attending
Vanderbilt University Medical Center

John Lu, MD
Attending
Private Practice

Dora Chen, MD
PGY-4
Vanderbilt University Medical Center

Connie Ju, MD
Attending
Louis Stokes Cleveland VA Medical Center
April 18th, 2026

Suzanna Tom, MD
PGY-2
Temple Chestnut Hill

Cindy Jiao, MD
Attending
University of Rochester

Hiu Ying Joanna Choi, MD
Attending
Temple University
April 19th, 2026

Anke Wang, MD
Critical Care Fellow
Duke University

William Hsu, MD
Critical Care Attending
Albany Medical Center

Chelsea Wu, MD
Medicine Attending
Baylor Medicine

Ramya Sampath, MD
PGY-3
Yale School of Medicine

Mingqian Lin, MD
PGY-2
Medical College of Wisconsin Affiliated Hospitals

Spenser Chen, MD
PGY-3
Children's Hospital of Philadelphia

Tiffany Hu, MD
Geriatrics Fellow
Yale School of Medicine
Alumni of the Year Award 2026
This award honors her enthusiastic participation in the APAMSA Alumni Advisory Board, commitment to AANHPI research, and dedication to mentoring APAMSA students.
Lindy Zhang, M.D., Ph.D. is Assistant Professor of Oncology and Pediatrics in the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. She is a child of immigrants and the first in her family to pursue a post-bachelor’s degree. Dr. Zhang completed her medical degree at the Albert Einstein College of Medicine with distinction in clinical research and her pediatrics residency at the Johns Hopkins Children’s Center. She then pursued a pediatric hematology-oncology fellowship at the combined Johns Hopkins-National Cancer Institute program. During her fellowship, she received additional translational research training by completing a PhD in Cellular and Molecular Medicine at the Johns Hopkins University School of Medicine. Her research focuses on NF1-associated tumors and the application of molecularly targeted therapies. Her academic interest is to define the interactions between molecularly targeted agents and the tumor immune microenvironment in malignant peripheral nerve sheath tumors (MPNST) and establish the potential role of immune-based therapies in novel therapeutic combinations. In addition, Dr. Zhang is passionate about diversity and inclusion in academic medicine. Her medical education research focuses on Asian American representation and experiences of microaggression and discrimination in medical school.
To read more about the APAMSA Alumni of the Year Award, click here.
Questions? Please reach out to strategy@apamsa.org.






